INDIA EXPORTED POISIONOUS SYRUP TO GAMBIA

INDIA EXPORTED POISIONOUS SYRUP TO GAMBIA

Gambia panel says India firm culpable for cough syrup deaths. WHO had issued an alert in October advising regulators to stop the sale of the syrups.

The WHO had advised regulators to stop the sale of the four Indian-made cough syrups
A parliamentary committee in The Gambia has recommended prosecution of the Indian manufacturer of cough syrups suspected of causing the deaths of at least 70 children in the country.

It said Maiden Pharmaceuticals should be held accountable for exporting what it called contaminated medicine.

The WHO had issued an alert in October advising regulators to stop the sale of the syrups.

Maiden Pharmaceuticals had denied the allegations.

Government labs in India said their tests on the syrups found that they were “complying with specifications”. An Indian official said last week that the WHO was “presumptuous” in blaming the syrups.

But the global health body told the BBC it was only following its mandate and “stands by the action taken”.

After weeks of investigation, the Gambian parliamentary committee has now recommended that authorities should take tough measures, including banning all Maiden Pharmaceuticals products in the country and taking legal action against the firm.

Gambia cough syrup deaths: ‘She is gone.’
Why drugs made in India are sparking safety concerns
The committee said it “is convinced that Maiden Pharmaceuticals [is] culpable and should be held accountable for exporting the contaminated medicines”.

“The findings remain the same with the previous reports which indicates that Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup were contaminated with diethylene glycol and ethylene glycol,” the parliamentary committee said in its report.

Diethylene glycol and ethylene glycol are toxic to humans and could be fatal if consumed. But the panel added that the exact scientific cause of the children’s deaths was still under investigation.

The committee also wanted the country’s Medicine Control Agency to ensure all medicines imported into the country are properly registered and background checks conducted on manufacturers – including visiting their facilities.

The report also revealed inadequacies in the country’s healthcare system urging the government to strengthen it and provide better equipment and medicines to the country’s hospitals.

Leave a Comment

Your email address will not be published. Required fields are marked *


Notice: ob_end_flush(): Failed to send buffer of zlib output compression (0) in /home/sirfpak1/public_html/wp-includes/functions.php on line 5427